-
Mashup Score: 23Long-Term Outcomes From Prostate Cancer Active Surveillance - 5 month(s) ago
This prospective, multicenter cohort study evaluates the long-term outcomes of men diagnosed with favorable-risk prostate cancer managed with protocol-directed active surveillance, including regular biopsies and prostate-specific antigen screening, from 2008 to 2022.
Source: jamanetwork.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 23Long-Term Outcomes From Prostate Cancer Active Surveillance - 5 month(s) ago
This prospective, multicenter cohort study evaluates the long-term outcomes of men diagnosed with favorable-risk prostate cancer managed with protocol-directed active surveillance, including regular biopsies and prostate-specific antigen screening, from 2008 to 2022.
Source: jamanetwork.comCategories: General Medicine News, Cardiologists1Tweet-
Long-Term Outcomes From Prostate Cancer Active Surveillance https://t.co/WpVAYqa8fJ; wondering what other disease patients had? Heart disease? OS at 15 years is almost 16%. PCSM is super low. @DanLinMD @wandering_gu @PCF_Science @neerajaiims @zklaassen_md
-
-
Mashup Score: 1Community Engagement to Advance Equitable Cardio-Oncology Care: A Call to Action: JACC: CardioOncology How To - 5 month(s) ago
Highlights •Situating engagement within the experience and priorities of survivors will enhance translational research and health equity.•The TRUST framework provides a guide to expand opportunitie…
Source: www.jacc.orgCategories: General Medicine News, Cardiologists1Tweet-
3/ Looking forward, to using the TRUST approach to develop tailored strategies for managing cardiovascular health in cancer patients. This study paves the way for future innovations in #CardioOncology. Check out the full article: https://t.co/95nthlw8jb #Research #Innovation https://t.co/5co7vbjMln
-
-
Mashup Score: 12
Introduction: The effect of diabetes mellitus (DM) and DM therapy on cardiovascular events (CVE) in patients with prostate cancer (PC) undergoing androgen deprivation therapy (ADT) is unclear in the
Source: www.ahajournals.orgCategories: General Medicine News, Cardiologists1Tweet-
Agree - speculative for a beneficial drug in the CV space and definitely in CV space for prostate cancer patients who are low risk and overwhelmingly (3 times more) die of heart disease https://t.co/8MnngGC9h2 https://t.co/NxltLXV4Jt https://t.co/Z46dYfawLI
-
-
Mashup Score: 1Thread by @SaadUrRahman55 on Thread Reader App - 8 month(s) ago
@SaadUrRahman55: Takeaways from #ACC2024. Late breaking trials – take home points @ACCinTouch 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the p……
Source: threadreaderapp.comCategories: General Medicine News, Cardiologists1Tweet-
RT @threadreaderapp: @kianboy @SaadUrRahman55 @ACCinTouch @kianboy Hello, please find the unroll here: https://t.co/CgU2IgPjlY Share this i…
-
-
Mashup Score: 6Examining the interplay between cardiovascular disease and cancer incidence: Data from NHANES III and continuous - 9 month(s) ago
This study aimed to investigate the relationship between risk factors of cancer among individuals with existing cardiovascular disease (CVD).The analy…
Source: www.sciencedirect.comCategories: General Medicine News, Cardiologists1Tweet-
RT @OelsayedMD: Did you know your🫀health could impact ⬆️your #Cancer risk? Check out our new findings https://t.co/oo4xdj6Coq #CardioOnc #…
-
-
Mashup Score: 8
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Cardiologists1Tweet-
Excellent presentation by mentor @neerajaiims - note the side effects in Cabo atezo was htn was the highest CTCAE 3+. Always finding a role for #cardioonc @ICOSociety recommend reviewing guidance in the 2022 guidelines for management: https://t.co/Afxpuhnpop https://t.co/nrGAnSODj1
-
-
Mashup Score: 3
Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA
Source: x.comCategories: General Medicine News, Cardiologists1Tweet-
Focus on increasing representation in clinical trials by recruiting patients underrepresented in all studies 1) RADICAL PC1 - Participants Active = 59 White= 25 Black= 32 2) REPLACE CV- Participants Active = 8 White= 3 Black= 5 Active community 👉🏽 https://t.co/3me4dIbuM9 4/x https://t.co/O6sfbi8MCW
-
-
Mashup Score: 1ICOS – International Cardioncology Society, North America - 12 month(s) ago
International CardioOncology Society
Source: ic-os.orgCategories: General Medicine News, Cardiologists1Tweet-
RT @ICOSociety: Please come join us in Minnesota in 2024 - https://t.co/ktclcup4Fm (website up soon) @MayoClinic @umnmedschool
-
-
Mashup Score: 1
PostAvirup Guha, MBBS, MPH, FICOS, FACC, FAHA@avirupguhaFinal Day of #AHA2023. Recollecting some excellent science presented by my group @AHAScience@ICOSociety@DocHariKris@NainPriyanshu@vrajpatel_@ritu_reddy2@GACancerCenter@MCG_AUG@mcg_urology . 1/9QuoteAvirup Guha, MBBS, MPH, FICOS, FACC, FAHA@avirupguhaNov 11Proud of mentee: @DrMCTan for oral presentation on Trends and Disparities in…
Source: x.comCategories: General Medicine News, Cardiologists1Tweet-
https://t.co/Qy9dymbA9Y https://t.co/MrEibNRq8o
-
Long-Term Outcomes From Prostate Cancer Active Surveillance https://t.co/WpVAYqa8fJ; wondering what other disease patients had? Heart disease? OS at 15 years is almost 16%. PCSM is super low. @DanLinMD @wandering_gu @PCF_Science @neerajaiims @zklaassen_md